en

PRODUCT DETAIL

Xtandi 40 mg mäkké kapsuly

Code 6336A
MA number EU/1/13/846/001
Product Form: cps mol 112x40 mg (blis.PVC/PCTFE/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Astellas Pharma Europe B.V., Netherland
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BB Anti-androgens
L02BB04 Enzalutamide
Shelf life: 36
Container: blister PVC/PCTFE/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 21.06.2013
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 21.06.2018
eu-flag.png sk-flag.png